• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Top Content 2020: Preventive Cardiology

Article

The most popular features in preventive cardiology this year were interviews with thought leaders on management of diabetes, hypertension, and hypercholesterolemia.

Harvard Cardiologist Talks T2D and ASCVD Risk Prevention

Video interview Jorge Plutzky, MD, Director, The Vascular Disease Prevention Program,
Director, Preventive Cardiology, Brigham and Women’s Hospital, Associate Professor, Cardiovascular Medicine, Harvard Medical School

Dr Plutzky discusses the extensive impact of diabetes on the cardiovascular system and its insidious role in comorbid disease, from stroke to peripheral neuropathy.

Plutzky emphasizes the essential role for all primary care clinicians in recognizing the risk factors for and earliest signs and symptoms of hyperglycemia and its broad metabolic impact and commends their front-line care.

Obesity Epidemic Could Stymie CVD Prevention Efforts

Video interview with Ted Kyle, RPh, founder of ConscienHealth, past chair of the Obesity Action Coalition, and long-time obesity policy advocate.

Kyle discusses the current understanding of obesity as a complex, chronic, relapsing disease that now threatens years of progress in reducing deaths related to cardiovascular disease.

ASCVD Risk Hit Hard by COVID-19: A Lipidologist's View

Video interview with Seth J Baum, MD, Founder, Chief Medical Officer, Excel Medical Clinical Trials, LLC, Clinical Affiliate Professor of Biomedical Science, Department of Integrated Medical Sciences, Florida Atlantic University Charles E. Schmidt College of Medicine

Dr Baum discusses the state of ASCVD risk in 2020 and highlights the potential COVID-19-related setbacks in cardiovascular health as healthy activity is limited and many individuals with chronic conditions, including hypertension, congestive heart failure, ACS, remain reluctant to make in-person appointments for follow-up.

Hypertension Treatment: "Put Simply, it's Complicated"

Video interview with Naomi DL Fisher, MD, Director, Hypertension Service & Hypertension Innovation, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital, Associate Professor of Medicine, Harvard Medical School

Dr Fisher spoke with us about clinical progress since the 2017 publication of lower cut points for a clinical diagnosis of hypertension; the state of blood pressure management in US primary care in 2020; and the significant challenges posed by patients with hypertension to the busy, office-based primary care clinician.


Tests of Clinical Guideline Knowledge

Patient Care Online© contributing physician author Veronica Hackethal, MD, poses basic, intermediate, and advanced questions on recommendations from a range of professional associations on management of cardiometabolic disease to prevent morbidity and mortality.

Managing Diabetes to Prevent Cardiovascular Disease: A Guideline Quiz

AHA/ACC Guidelines on Obesity Management for CVD Prevention: 5 Questions

5 Questions on How to Manage Hypertension in Primary Care

Lipid Management to Reduce ASCVD Risk: What Would AHA/ACC Do?

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
© 2024 MJH Life Sciences

All rights reserved.